Annual EBITDA
-$36.57 M
-$4.58 M-14.31%
31 December 2023
Summary:
Lumos Pharma annual earnings before interest, taxes, depreciation & amortization is currently -$36.57 million, with the most recent change of -$4.58 million (-14.31%) on 31 December 2023. During the last 3 years, it has fallen by -$5.44 million (-17.48%).LUMO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$7.64 M
+$181.00 K+2.31%
30 September 2024
Summary:
Lumos Pharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$7.64 million, with the most recent change of +$181.00 thousand (+2.31%) on 30 September 2024. Over the past year, it has increased by +$2.35 million (+23.49%).LUMO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$36.31 M
+$1.28 M+3.42%
30 September 2024
Summary:
Lumos Pharma TTM earnings before interest, taxes, depreciation & amortization is currently -$36.31 million, with the most recent change of +$1.28 million (+3.42%) on 30 September 2024. Over the past year, it has increased by +$263.00 thousand (+0.72%).LUMO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +23.5% | +0.7% |
| 3 y3 years | -17.5% | -16.3% | -16.6% |
| 5 y5 years | -274.0% | -210.7% | -271.3% |
LUMO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -130.8% | -105.1% | -125.8% |
Lumos Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.64 M(-2.3%) | -$36.31 M(-3.4%) |
| June 2024 | - | -$7.82 M(-28.0%) | -$37.59 M(-4.6%) |
| Mar 2024 | - | -$10.86 M(+8.8%) | -$39.40 M(+7.7%) |
| Dec 2023 | -$36.57 M(+14.3%) | -$9.99 M(+11.9%) | -$36.57 M(+3.4%) |
| Sept 2023 | - | -$8.92 M(-7.4%) | -$35.38 M(+4.1%) |
| June 2023 | - | -$9.63 M(+20.0%) | -$34.01 M(-15.0%) |
| Mar 2023 | - | -$8.03 M(-8.8%) | -$40.03 M(+0.8%) |
| Dec 2022 | -$31.99 M(+2.8%) | -$8.80 M(+16.6%) | -$39.72 M(+6.0%) |
| Sept 2022 | - | -$7.55 M(-51.8%) | -$37.49 M(+0.2%) |
| June 2022 | - | -$15.65 M(+102.8%) | -$37.43 M(+23.0%) |
| Mar 2022 | - | -$7.72 M(+17.5%) | -$30.43 M(-2.3%) |
| Dec 2021 | -$31.13 M(+21.0%) | -$6.57 M(-12.2%) | -$31.13 M(-18.4%) |
| Sept 2021 | - | -$7.49 M(-13.5%) | -$38.13 M(+22.4%) |
| June 2021 | - | -$8.65 M(+2.7%) | -$31.16 M(+7.2%) |
| Mar 2021 | - | -$8.42 M(-37.9%) | -$29.08 M(+13.1%) |
| Dec 2020 | -$25.72 M(+163.0%) | -$13.57 M(+2551.0%) | -$25.72 M(+76.1%) |
| Sept 2020 | - | -$512.00 K(-92.2%) | -$14.61 M(-12.9%) |
| June 2020 | - | -$6.57 M(+29.6%) | -$16.76 M(+31.4%) |
| Mar 2020 | - | -$5.07 M(+106.0%) | -$12.75 M(+30.4%) |
| Dec 2019 | -$9.78 M(-83.5%) | -$2.46 M(-7.8%) | -$9.78 M(-44.5%) |
| Sept 2019 | - | -$2.67 M(+4.1%) | -$17.62 M(-39.4%) |
| June 2019 | - | -$2.56 M(+22.3%) | -$29.08 M(-33.1%) |
| Mar 2019 | - | -$2.09 M(-79.7%) | -$43.50 M(-26.7%) |
| Dec 2018 | -$59.37 M(-16.4%) | -$10.30 M(-27.1%) | -$59.37 M(-5.1%) |
| Sept 2018 | - | -$14.13 M(-16.8%) | -$62.53 M(-9.1%) |
| June 2018 | - | -$16.97 M(-5.5%) | -$68.79 M(+0.9%) |
| Mar 2018 | - | -$17.96 M(+33.4%) | -$68.19 M(-3.9%) |
| Dec 2017 | -$70.98 M | -$13.47 M(-33.9%) | -$70.98 M(+0.3%) |
| Sept 2017 | - | -$20.39 M(+24.5%) | -$70.80 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$16.37 M(-21.1%) | -$66.93 M(-20.7%) |
| Mar 2017 | - | -$20.76 M(+56.2%) | -$84.41 M(-4.5%) |
| Dec 2016 | -$88.41 M(+176.7%) | -$13.29 M(-19.5%) | -$88.41 M(-1.1%) |
| Sept 2016 | - | -$16.51 M(-51.2%) | -$89.42 M(+1.5%) |
| June 2016 | - | -$33.85 M(+36.8%) | -$88.13 M(+26.1%) |
| Mar 2016 | - | -$24.75 M(+73.0%) | -$69.87 M(+118.7%) |
| Dec 2015 | -$31.95 M(-126.9%) | -$14.31 M(-6.0%) | -$31.95 M(-124.3%) |
| Sept 2015 | - | -$15.21 M(-2.4%) | $131.70 M(-1.9%) |
| June 2015 | - | -$15.59 M(-218.4%) | $134.20 M(-4.8%) |
| Mar 2015 | - | $13.17 M(-91.2%) | $140.90 M(+18.6%) |
| Dec 2014 | $118.76 M(-494.2%) | $149.33 M(-1275.0%) | $118.76 M(-410.6%) |
| Sept 2014 | - | -$12.71 M(+42.9%) | -$38.23 M(+14.4%) |
| June 2014 | - | -$8.89 M(-0.9%) | -$33.43 M(+6.5%) |
| Mar 2014 | - | -$8.97 M(+17.3%) | -$31.39 M(+4.2%) |
| Dec 2013 | -$30.13 M(+33.9%) | -$7.65 M(-3.2%) | -$30.13 M(+5.5%) |
| Sept 2013 | - | -$7.91 M(+15.3%) | -$28.57 M(+8.6%) |
| June 2013 | - | -$6.85 M(-11.1%) | -$26.30 M(+3.0%) |
| Mar 2013 | - | -$7.71 M(+26.6%) | -$25.55 M(+13.6%) |
| Dec 2012 | -$22.50 M(+29.6%) | -$6.09 M(+7.9%) | -$22.50 M(+2.1%) |
| Sept 2012 | - | -$5.64 M(-7.5%) | -$22.04 M(+9.1%) |
| June 2012 | - | -$6.10 M(+30.9%) | -$20.19 M(+10.3%) |
| Mar 2012 | - | -$4.66 M(-17.3%) | -$18.30 M(+5.4%) |
| Dec 2011 | -$17.36 M(+9.5%) | -$5.63 M(+48.3%) | -$17.36 M(+10.3%) |
| Sept 2011 | - | -$3.80 M(-9.9%) | -$15.74 M(-6.5%) |
| June 2011 | - | -$4.22 M(+13.5%) | -$16.84 M(+33.4%) |
| Mar 2011 | - | -$3.71 M(-7.5%) | -$12.62 M(+41.7%) |
| Dec 2010 | -$15.86 M(+57.9%) | -$4.01 M(-18.0%) | -$8.91 M(+19.7%) |
| Sept 2010 | - | -$4.89 M(+92.4%) | -$7.44 M(+192.4%) |
| Dec 2009 | -$10.05 M(+10.1%) | -$2.54 M | -$2.54 M |
| Dec 2008 | -$9.12 M | - | - |
FAQ
- What is Lumos Pharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Lumos Pharma?
- What is Lumos Pharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Lumos Pharma?
- What is Lumos Pharma quarterly EBITDA year-on-year change?
- What is Lumos Pharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Lumos Pharma?
- What is Lumos Pharma TTM EBITDA year-on-year change?
What is Lumos Pharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of LUMO is -$36.57 M
What is the all time high annual EBITDA for Lumos Pharma?
Lumos Pharma all-time high annual earnings before interest, taxes, depreciation & amortization is $118.76 M
What is Lumos Pharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of LUMO is -$7.64 M
What is the all time high quarterly EBITDA for Lumos Pharma?
Lumos Pharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is $149.33 M
What is Lumos Pharma quarterly EBITDA year-on-year change?
Over the past year, LUMO quarterly earnings before interest, taxes, depreciation & amortization has changed by +$2.35 M (+23.49%)
What is Lumos Pharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of LUMO is -$36.31 M
What is the all time high TTM EBITDA for Lumos Pharma?
Lumos Pharma all-time high TTM earnings before interest, taxes, depreciation & amortization is $140.90 M
What is Lumos Pharma TTM EBITDA year-on-year change?
Over the past year, LUMO TTM earnings before interest, taxes, depreciation & amortization has changed by +$263.00 K (+0.72%)